ENTO logo

Entero Therapeutics (ENTO) Selling, General & Administrative Expenses

Annual SGA

$10.74 M
-$1.25 M-10.42%

December 31, 2023

Summary

Performance

1-Year Change

-10.42%

3-Year Change

+47.2%

5-Year Change

+44.12%

15-Year Change

+39.71%

ENTO SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

23.83%
ENTO annual SGA is higher than 23.83% of companies in Healthcare sector

High & Low

All-time High

$18.38 M
ENTO annual SGA is currently -41.59% below its historical high of $18.38 million

3-Year Low

$10.74 M
ENTO annual SGA is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
ENTO previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

May 14, 2025
ENTO next annual earnings announcement is scheduled for May 14, 2025

OtherENTOexpensesmetrics:

Annual Total Expenses

$15.77 M
ENTO annual total expenses is $15.77 million

Annual Operating Expenses

$15.77 M
ENTO annual total operating expenses is $15.77 million

Annual Cost Of Goods Sold

-
ENTO annual cost of goods sold value is unknown

Annual Interest Expense

$22.50 K
ENTO annual interest expense is $22.50 thousand

Quarterly SGA

$1.69 M
-$1.52 M-47.43%

September 1, 2024

Summary

Performance

3-Month Change

-47.43%

1-Year Change

-39.5%

3-Year Change

-37.59%

5-Year Change

-9.38%

ENTO Quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

14.48%
ENTO quarterly SGA is higher than 14.48% of companies in Healthcare sector

High & Low

All-time High

$8.66 M
ENTO quarterly SGA is currently -80.54% below its historical high of $8.66 million

3-Year Low

$1.69 M
ENTO quarterly SGA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
ENTO previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

May 14, 2025
ENTO next earnings announcement is scheduled for May 14, 2025

OtherENTOexpensesmetrics:

Quarterly Total Expenses

$1.89 M
ENTO quarterly total expenses is $1.89 million

Quarterly Operating Expenses

$1.89 M
ENTO quarterly total operating expenses is $1.89 million

Quarterly Cost Of Goods Sold

-
ENTO quarterly cost of goods sold value is unknown

Quarterly Interest Expense

-
ENTO quarterly interest expense value is unknown

TTM SGA

-$740.81 M
-$9.92 M-1.36%

September 1, 2024

Summary

Performance

3-Month Change

-4438.68%

1-Year Change

-6999.26%

3-Year Change

-7304.97%

5-Year Change

-13167.48%

ENTO TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

53.92%
ENTO TTM SGA is higher than 53.92% of companies in Healthcare sector

High & Low

All-time High

-$8.30 M

3-Year Low

-$740.81 M
ENTO TTM SGA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
ENTO previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

May 14, 2025
ENTO next earnings announcement is scheduled for May 14, 2025

OtherENTOexpensesmetrics:

Annual Total Expenses

$15.77 M
ENTO annual total expenses is $15.77 million

Annual Operating Expenses

$15.77 M
ENTO annual total operating expenses is $15.77 million

TTM Cost Of Goods Sold

-
ENTO TTM cost of goods sold value is unknown

TTM Interest Expense

-
ENTO TTM interest expense value is unknown

Selling, General & Administrative Expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

Annual SGA

$10.74 M
ENTO annual SGA is $10.74 million

Annual Operating Expenses

$15.77 M
ENTO annual total operating expenses is $15.77 million

Annual Cost Of Goods Sold

-
ENTO annual cost of goods sold value is unknown

ENTO Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-10.4%-39.5%-6999.3%
3 y3 years+47.2%-37.6%-7305.0%
5 y5 years+44.1%-9.4%-10000.0%

ENTO Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-41.6%at low-80.5%at low-44.7%at low
5 y5-year-41.6%+77.1%-80.5%+351.8%-217.3%at low
alltimeall time-41.6%+222.4%-80.5%+351.8%-8830.4%at low

Entero Therapeutics Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Sep 2024
-
$1.69 M(-47.4%)
$16.34 M(-4.3%)
Jun 2024
-
$3.21 M(-63.0%)
$17.07 M(+2.3%)
Mar 2024
-
$8.66 M(+210.8%)
$16.70 M(+55.5%)
Dec 2023
$10.74 M(-10.4%)
$2.79 M(+15.0%)
$10.74 M(+6.0%)
Sep 2023
-
$2.42 M(-14.4%)
$10.13 M(-4.5%)
Jun 2023
-
$2.83 M(+4.7%)
$10.61 M(+3.2%)
Mar 2023
-
$2.70 M(+24.0%)
$10.28 M(-14.2%)
Dec 2022
$11.99 M(-34.8%)
-
-
Dec 2022
-
$2.18 M(-25.0%)
$11.99 M(-6.7%)
Sep 2022
-
$2.90 M(+16.2%)
$12.85 M(-19.5%)
Jun 2022
-
$2.50 M(-43.3%)
$15.96 M(-6.6%)
Mar 2022
-
$4.41 M(+45.1%)
$17.09 M(-7.0%)
Dec 2021
$18.38 M(+152.0%)
$3.04 M(-49.6%)
$18.38 M(+1.9%)
Sep 2021
-
$6.02 M(+65.9%)
$18.05 M(+29.4%)
Jun 2021
-
$3.63 M(-36.3%)
$13.94 M(+20.0%)
Mar 2021
-
$5.70 M(+111.1%)
$11.62 M(+59.2%)
Dec 2020
$7.29 M(+20.3%)
$2.70 M(+40.8%)
$7.30 M(+46.8%)
Sep 2020
-
$1.92 M(+46.9%)
$4.97 M(+1.1%)
Jun 2020
-
$1.30 M(-5.4%)
$4.92 M(-13.3%)
Mar 2020
-
$1.38 M(+269.8%)
$5.67 M(-3.6%)
DateAnnualQuarterlyTTM
Dec 2019
$6.06 M(-18.6%)
$373.10 K(-79.9%)
$5.88 M(-22.2%)
Sep 2019
-
$1.86 M(-9.5%)
$7.56 M(+7.7%)
Jun 2019
-
$2.06 M(+29.0%)
$7.02 M(-1.6%)
Mar 2019
-
$1.59 M(-22.2%)
$7.13 M(-4.3%)
Dec 2018
$7.45 M(-3.1%)
$2.05 M(+55.6%)
$7.45 M(-0.9%)
Sep 2018
-
$1.32 M(-39.2%)
$7.52 M(-8.4%)
Jun 2018
-
$2.17 M(+13.1%)
$8.21 M(+10.6%)
Mar 2018
-
$1.92 M(-9.6%)
$7.43 M(-3.4%)
Dec 2017
$7.69 M(+86.1%)
$2.12 M(+5.5%)
$7.69 M(+1.1%)
Sep 2017
-
$2.01 M(+45.5%)
$7.60 M(+23.9%)
Jun 2017
-
$1.38 M(-36.5%)
$6.14 M(+8.8%)
Mar 2017
-
$2.17 M(+6.6%)
$5.64 M(+36.6%)
Dec 2016
$4.13 M(+24.0%)
$2.04 M(+275.1%)
$4.13 M(+47.7%)
Sep 2016
-
$543.70 K(-38.5%)
$2.79 M(-15.2%)
Jun 2016
-
$884.30 K(+33.7%)
$3.30 M(+2.1%)
Mar 2016
-
$661.60 K(-6.2%)
$3.23 M(-3.1%)
Dec 2015
$3.33 M
$705.20 K(-32.5%)
$3.33 M(+26.9%)
Sep 2015
-
$1.04 M(+27.9%)
$2.63 M(+66.1%)
Jun 2015
-
$817.00 K(+7.0%)
$1.58 M(+107.0%)
Mar 2015
-
$763.60 K
$763.60 K

FAQ

  • What is Entero Therapeutics annual SGA?
  • What is the all time high annual SGA for Entero Therapeutics?
  • What is Entero Therapeutics annual SGA year-on-year change?
  • What is Entero Therapeutics quarterly SGA?
  • What is the all time high quarterly SGA for Entero Therapeutics?
  • What is Entero Therapeutics quarterly SGA year-on-year change?
  • What is Entero Therapeutics TTM SGA?
  • What is the all time high TTM SGA for Entero Therapeutics?
  • What is Entero Therapeutics TTM SGA year-on-year change?

What is Entero Therapeutics annual SGA?

The current annual SGA of ENTO is $10.74 M

What is the all time high annual SGA for Entero Therapeutics?

Entero Therapeutics all-time high annual SGA is $18.38 M

What is Entero Therapeutics annual SGA year-on-year change?

Over the past year, ENTO annual SGA has changed by -$1.25 M (-10.42%)

What is Entero Therapeutics quarterly SGA?

The current quarterly SGA of ENTO is $1.69 M

What is the all time high quarterly SGA for Entero Therapeutics?

Entero Therapeutics all-time high quarterly SGA is $8.66 M

What is Entero Therapeutics quarterly SGA year-on-year change?

Over the past year, ENTO quarterly SGA has changed by -$1.10 M (-39.50%)

What is Entero Therapeutics TTM SGA?

The current TTM SGA of ENTO is -$740.81 M

What is the all time high TTM SGA for Entero Therapeutics?

Entero Therapeutics all-time high TTM SGA is -$8.30 M

What is Entero Therapeutics TTM SGA year-on-year change?

Over the past year, ENTO TTM SGA has changed by -$751.55 M (-6999.26%)